Barbara K. Finck

Acting Chief Medical Officer

Dr. Finck is a board certified rheumatologist with more than 25 years of preclinical and clinical drug development experience in academic and biopharmaceutical settings. During her rheumatology training at University of California, San Francisco she studied the effects of CTLA4-Ig (subsequently developed and marketed as Orencia®) in a murine lup...

Roles at Coherus BioSciences

  • Acting Chief Medical Officer

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.